: Heterologous expression of the YfiP homolog from C. saccharoperbutylacetonicum in E. coli yields a well-folded protein. CD spectrum of 15 µM C. saccharoperbutylacetonicum YfiP at 20°C. The spectrum was recorded in 25 mM sodium phosphate and 25 mM NaCl, pH 7.5 with a Jasco J-810 spectropolarimeter (Jasco).
coli YfiP, which elutes at ~12 ml on a Superdex 75 10/300 GL column (GE Healthcare). The absorption is shown at 280 and 260 nm. Elution volumes of molecular size standards are indicated. In comparison with the size standards, the elution volume of YfiP (expected mass monomer: 26.84 kDa) corresponds to a monomer with a molecular weight of ~26.24 kDa. (C) MALDI-TOF spectrum of purified full-length YfiP. The observed mass is in agreement with the expected mass of 26.84 kDa. (D) UV-Vis spectrum of 370 µM purified YfiP recorded at a Nanodrop2000c spectrophotometer (Thermo Fisher Scientific). The absorbance profile does not indicate the presence of a bound iron sulfur cluster or of bound SAM. (E) CD spectrum of 6.5 µM YfiP at 20°C. The spectrum was recorded in 50 mM sodium phosphate and 50 mM NaCl, pH 7.5 at a Jasco J-810 spectropolarimeter (Jasco) and clearly indicates a well-folded protein. Figure S4 : Individual RP-HPLC elution profiles of tRNA nucleosides from wild type (black) and ΔtrmB deleted (red) E. coli cells corresponding to three additional biological replicates. Q, queuosine; ς , epoxyqueuosine. Figure S5 : Individual RP-HPLC elution profiles of tRNA nucleosides from wild type E. coli cells cultivated in LB (black) or M9 (red) medium corresponding to three additional biological replicates (n=3). Q, queuosine; ς , epoxyqueuosine. Figure S6 : The stability of the tRNA Arg -ICG was analyzed by northern blotting as described for Figure 9B . Two additional biological replicates of each strain (wildtype, ΔyfiP and ΔyfiP ΔtrmB) were cultivated with the transcription inhibitors rifampicin and nalidixic acid for the indicated amounts of time (hours). See also figure caption to Figure 9B . Supplementary Table S6 : Quantification of the modified nucleosides acp 3 U and m 7 G from three independent biological replicates by measuring the ratios between the integrated peak areas from the respective HPLC chromatograms shown in Fig. S4 and Fig. S5 for the acp 3 U signal and the total peak area over all peaks in the chromatogram (acp 3 U/total) or between the acp 3 U signal and the individual signals for the unmodified U, C, G and A nucleosides, respectively. For comparison, the relative amount of m 7 G in each chromatogram was also quantified in this way. No m 7 G is present in the trmB samples.
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